Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219)

被引:42
|
作者
Kenny, GE
Cartwright, FD
机构
关键词
D O I
10.1128/AAC.40.4.1048
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The susceptibilities of mycoplasmas to a new quinolone, trovafloxacin (CP-99,219), were compared,vith those to sparfloxacin and ofloxacin, Mycoplasma pneumoniae was as susceptible to trovafloxacin (MIC = 0.25 mu g/ml) as to sparfloxacin and fourfold less susceptible to ofloxacin. Mycoplasma hominis was highly susceptible to trovafloxacin (MIC = 0.06 mu g/ml) and sparfloxacin (MIC = 0.03 mu g/ml) and less susceptible to ofloxacin (MIC = 0.5 mu g/ml). Ureaplasma urealyticum was most susceptible to trovafloxacin, with susceptibilities ranging from 0.06 to 0.5 mu g/ml compared with 0.25 to 1.0 mu g of sparfloxacin per ml and 1 to 4 mu g of ofloxacin per ml .
引用
收藏
页码:1048 / 1049
页数:2
相关论文
共 50 条
  • [31] Bacteremia with Mycoplasma hominis and Ureaplasma urealyticum in patients undergoing hysterectomy
    Daxboeck, F
    Iro, E
    Tamussino, K
    Krause, R
    Assadian, O
    Wenisch, C
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (10) : 608 - 611
  • [32] Evaluation of the Etest for susceptibility testing of Mycoplasma hominis and Ureaplasma urealyticum
    Dósa, E
    Nagy, E
    Falk, W
    Szoke, I
    Ballies, U
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) : 575 - 578
  • [33] Examination of Ureaplasma urealyticum and Mycoplasma hominis in 4082 Chinese patients
    Zheng, Wei-wei
    Zhang, Wen-jing
    Cui, Di
    Nie, Zheng-chao
    Ding, Bang-sheng
    Cheng, Jiang-hua
    Mei, Chuan-zhong
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2021, 54 (02) : 1 - 4
  • [34] Bacteremia with Mycoplasma hominis and Ureaplasma urealyticum in Patients Undergoing Hysterectomy
    F. Daxboeck
    E. Iro
    K. Tamussino
    R. Krause
    O. Assadian
    C. Wenisch
    European Journal of Clinical Microbiology and Infectious Diseases , 2003, 22 : 608 - 611
  • [35] Mycoplasma hominis and Ureaplasma urealyticum in patients with sexually transmitted diseases
    Koch, A
    Bilina, A
    Teodorowicz, L
    Stary, A
    WIENER KLINISCHE WOCHENSCHRIFT, 1997, 109 (14-15) : 584 - 589
  • [36] Prevalence of Mycoplasma Hominis and Ureaplasma Urealyticum in Patients with Urogenital Symptoms
    Bilir, Yesim Aybar
    Pehlivanoglu, Filiz
    Yasar, Kadriye Kart
    Sengoz, Gonul
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2011, 49 (03): : 99 - 101
  • [37] GLYCOCONJUGATES AND LECTINS IN MYCOPLASMA-HOMINIS AND UREAPLASMA-UREALYTICUM
    BLENK, H
    ARNDT, R
    BIALASIEWICZ, AA
    BLENK, B
    GRANING, G
    THIELE, HG
    ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY, 1982, 251 (04): : 466 - 467
  • [38] GLYCOCONJUGATES AND LECTINS IN MYCOPLASMA-HOMINIS AND UREAPLASMA-UREALYTICUM
    BLENK, H
    ARNDT, R
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1982, 20 (03): : 124 - 124
  • [39] VAGINAL COLONIZATION WITH MYCOPLASMA-HOMINIS AND UREAPLASMA-UREALYTICUM
    MCCORMACK, WM
    ROSNER, B
    ALPERT, S
    EVRARD, JR
    CROCKETT, VA
    ZINNER, SH
    SEXUALLY TRANSMITTED DISEASES, 1986, 13 (02) : 67 - 70
  • [40] IN-VIVO EFFICACY OF TROVAFLOXACIN (CP-99,219), A NEW QUINOLONE WITH EXTENDED ACTIVITIES AGAINST GRAM-POSITIVE PATHOGENS, STREPTOCOCCUS-PNEUMONIAE, AND BACTEROIDES-FRAGILIS
    GIRARD, AE
    GIRARD, D
    GOOTZ, TD
    FAIELLA, JA
    CIMOCHOWSKI, CR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (10) : 2210 - 2216